Clinical Multidisciplinary Hematology and Oncology: The 19th Annual Review - 2025
By
Event Details
Clinical Multidisciplinary Hematology and Oncology: The 19th Annual Review - 2025
This course offers attendees a comprehensive update in the diagnosis and management of key diseases in hematology and medical oncology. Presentations provide updates on new data and best practices for physicians and the healthcare team. The format for this activity is didactic presentations followed by Q and A sessions. In person and virtual attendance will be offered. Continuing medical education credits will be offered for physicians, APPs, pharmacists, and nurses.
Upon completion of this activity, participants should be able to:
-Identify optimal treatment selection for castrate-resistant prostate cancer patients.
-Identify targeted therapy for IDH 1 and 2 mutant grade 2 glioma patients.
-Review the first-line treatment options for metastatic colorectal cancer patients.
-Recognize different ways to manage stage III lung cancer.
-Identify the role of immunotherapy in the treatment of triple-negative breast cancer patients.
-Review the indications for bispecific T cell engagers (bispecific antibodies) in lymphoma.
-Review the potential toxicities and toxicity management for multiple myeloma patients receiving CART or bispecific antibodies.
-Describe the application of newly approved drugs for classical hematology.
-Identify treatment strategies for Richter's transformation.
URL:
Tickets: https://go.evvnt.com/2619476-0?pid=10018
Prices:
Live (In-Person) - M.D., Ph.D., D.O. (Before December 12, 2024): USD 950.00,
Live (In-Person) - Allied Health, NP, PA, Residents, Fellows, Retired (Before December 12, 2024): USD 750.00,
Live (In-Person) - M.D., Ph.D., D.O. (After December 12, 2024): USD 1025.00,
Live (In-Person) - Allied Health, NP, PA, Residents, Fellows, Retired (After December 12, 2024): USD 825.00,
Virtual (Livestream) - M.D., Ph.D., D.O.: USD 950.00,
Virtual (Livestream) - Allied Health, NP, PA, Residents, Fellows, Retired: USD 750.00
Speakers: Christina S. Wu, M.B., B.Ch., M.D., Allison C. Rosenthal, D.O., Carol P. Bryant, APRN, D.N.P., ACNP-BC
Upon completion of this activity, participants should be able to:
-Identify optimal treatment selection for castrate-resistant prostate cancer patients.
-Identify targeted therapy for IDH 1 and 2 mutant grade 2 glioma patients.
-Review the first-line treatment options for metastatic colorectal cancer patients.
-Recognize different ways to manage stage III lung cancer.
-Identify the role of immunotherapy in the treatment of triple-negative breast cancer patients.
-Review the indications for bispecific T cell engagers (bispecific antibodies) in lymphoma.
-Review the potential toxicities and toxicity management for multiple myeloma patients receiving CART or bispecific antibodies.
-Describe the application of newly approved drugs for classical hematology.
-Identify treatment strategies for Richter's transformation.
URL:
Tickets: https://go.evvnt.com/2619476-0?pid=10018
Prices:
Live (In-Person) - M.D., Ph.D., D.O. (Before December 12, 2024): USD 950.00,
Live (In-Person) - Allied Health, NP, PA, Residents, Fellows, Retired (Before December 12, 2024): USD 750.00,
Live (In-Person) - M.D., Ph.D., D.O. (After December 12, 2024): USD 1025.00,
Live (In-Person) - Allied Health, NP, PA, Residents, Fellows, Retired (After December 12, 2024): USD 825.00,
Virtual (Livestream) - M.D., Ph.D., D.O.: USD 950.00,
Virtual (Livestream) - Allied Health, NP, PA, Residents, Fellows, Retired: USD 750.00
Speakers: Christina S. Wu, M.B., B.Ch., M.D., Allison C. Rosenthal, D.O., Carol P. Bryant, APRN, D.N.P., ACNP-BC
Entry Fees
Free Registration
Categories
Event Frequency
One Time
Event Timings
(GMT-7:00) Pacific Time (US and Canada)
12:00 PM - 12:50 PM (Mar 12, Mar 13, Mar 14, Mar 15) (Public)
Speakers
Organizer
Mayo Clinic School of Continuous Professional Development
1 Followers
Follow
MCSCPD is an accredited, not-for-profit school within Mayo Clinic College of Medicine. We develop and maintain educational activities to enhance medical knowledge and improve service to the patient.
More Events By Mayo Clinic School of Continuous Professional Development
10th Mayo Clinic Symposium on Immuno-Oncology and Tumor Microenvironment Crosstalk 2024
37th Annual Selected Topics in Internal Medicine
Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2025
Mayo Clinic: Tackling Problematic Sinusitis 2025
Mayo Clinic: ENT Updates 2025
Hospital Medicine for NPs and PAs - Desert Edition 2025
Comments on Clinical Multidisciplinary Hematology and Oncology: The 19th Annual Review - 2025
You must Login to write a comment.
Peoples Interested in Visit
0 Peoples Interested to Visit
Event Location
The Westin Kierland Resort & Spa
6902 East Greenway Parkway ,
Scottsdale 85254, Arizona, United States
Scottsdale 85254, Arizona, United States
Official Link :